DLG3-AS1

Across TCGA pan-cancer cohorts, DLG3-AS1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of DLG3-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where DLG3-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DLG3-AS1 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

LUAD, THCA, and BRCA are the cancer types where DLG3-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLG3-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	+0.772	<.001	11	view →
THCA	Male	All	−0.817	<.001	9	view →
BRCA	All	All	+0.620	<.001	6	view →
STAD	All	All	+0.428	.004	5	view →
BLCA	All	All	+0.393	.002	5	view →
KIRP	All	All	+0.506	<.001	4	view →
CHOL	All	All	+0.515	<.001	3	view →
KICH	All	III,IV	−0.352	.011	3	view →
LUSC	Female	All	+1.077	.015	2	view →
PRAD	All	All	+0.917	<.001	2	view →
PAAD	Male	All	+0.420	.048	2	view →
LIHC	Female	All	+0.089	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

DLG3-AS1–LUAD

Open the LUAD breakdown →